Biotech funding is available - for companies with a clear plan
This article was originally published in Scrip
Executive Summary
2009 may have been a lean year for biotech firms, but things seem to be looking up and some small companies may well fare better financially this year than their pharma peers, provided they have a good product, a strong business plan and a clear exit strategy.